Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 308382 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study a comparison was made on the influence of missing pills on follicular ripening. By missing a given number of pills, an effect on "contraceptive robustness" of the two investigated contraceptive pills was measured by ultrasound comparison of follicular size and other parameters which indicate how far ovulation might be.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 2 | Active Comparator |
| |
| Arm 1 | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) | Drug | SH T 00186 D in a 24-day regimen, i.e., 24 verum tablets, 4 placebo tablets Dose: 0.02 mg EE, 3 mg DRSPMode of administration: Oral, 1 tablet dailyDuration of treatment: 3 cycles of 28 days each |
| Measure | Description | Time Frame |
|---|---|---|
| Hoogland scores in cycles 2 and 3 | Treatment cycles 2 and 3 (treatment weeks 5-12) |
| Measure | Description | Time Frame |
|---|---|---|
| Follicle size | Treatment cycles 2 and 3 (treatment weeks 5-12 | |
| Hormone levels of progesterone, estradiol, luteinizing hormone, follicle stimulating hormone | Treatment cycles 2 and 3 (treatment weeks 5-12 |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bayer Study Director | Bayer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Groningen | 9713 GZ | Netherlands |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21721590 | Result | Anttila L, Neunteufel W, Petraglia F, Marr J, Kunz M. Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 mug compared with a 21/7 regimen of desogestrel 150 mug/ethinylestradiol 20 mug: a pooled analysis. Clin Drug Investig. 2011;31(8):519-525. doi: 10.2165/11590260-000000000-00000. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C534342 | drospirenone and ethinyl estradiol combination |
| C035144 | drospirenone |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Yasminelle (SH T 00186 D) | Drug | SH T 00186 D in a 21-day regimen, i.e., 21 verum tablets, 7 placebo tablets Dose: 0.02 mg EE, 3 mg DRSPMode of administration: Oral, 1 tablet dailyDuration of treatment: 3 cycles of 28 days each |
|
| Endometrial thickness | Treatment cycles 2 and 3 (treatment weeks 5-12 |
| Cervical mucus | Treatment cycles 2 and 3 (treatment weeks 5-12 |